Cargando…

Generation of Neutralizing Antibodies and Divergence of SIVmac239 in Cynomolgus Macaques Following Short-Term Early Antiretroviral Therapy

Neutralizing antibodies (NAb) able to react to heterologous viruses are generated during natural HIV-1 infection in some individuals. Further knowledge is required in order to understand the factors contributing to induction of cross-reactive NAb responses. Here a well-established model of experimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Özkaya Şahin, Gülşen, Bowles, Emma J., Parker, Joe, Uchtenhagen, Hannes, Sheik-Khalil, Enas, Taylor, Stephen, Pybus, Oliver G., Mäkitalo, Barbro, Walther-Jallow, Lilian, Spångberg, Mats, Thorstensson, Rigmor, Achour, Adnane, Fenyö, Eva Maria, Stewart-Jones, Guillaume B. E., Spetz, Anna-Lena
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932721/
https://www.ncbi.nlm.nih.gov/pubmed/20824092
http://dx.doi.org/10.1371/journal.ppat.1001084
_version_ 1782186094760034304
author Özkaya Şahin, Gülşen
Bowles, Emma J.
Parker, Joe
Uchtenhagen, Hannes
Sheik-Khalil, Enas
Taylor, Stephen
Pybus, Oliver G.
Mäkitalo, Barbro
Walther-Jallow, Lilian
Spångberg, Mats
Thorstensson, Rigmor
Achour, Adnane
Fenyö, Eva Maria
Stewart-Jones, Guillaume B. E.
Spetz, Anna-Lena
author_facet Özkaya Şahin, Gülşen
Bowles, Emma J.
Parker, Joe
Uchtenhagen, Hannes
Sheik-Khalil, Enas
Taylor, Stephen
Pybus, Oliver G.
Mäkitalo, Barbro
Walther-Jallow, Lilian
Spångberg, Mats
Thorstensson, Rigmor
Achour, Adnane
Fenyö, Eva Maria
Stewart-Jones, Guillaume B. E.
Spetz, Anna-Lena
author_sort Özkaya Şahin, Gülşen
collection PubMed
description Neutralizing antibodies (NAb) able to react to heterologous viruses are generated during natural HIV-1 infection in some individuals. Further knowledge is required in order to understand the factors contributing to induction of cross-reactive NAb responses. Here a well-established model of experimental pathogenic infection in cynomolgus macaques, which reproduces long-lasting HIV-1 infection, was used to study the NAb response as well as the viral evolution of the highly neutralization-resistant SIVmac239. Twelve animals were infected intravenously with SIVmac239. Antiretroviral therapy (ART) was initiated ten days post-inoculation and administered daily for four months. Viral load, CD4(+) T-cell counts, total IgG levels, and breadth as well as strength of NAb in plasma were compared simultaneously over 14 months. In addition, envs from plasma samples were sequenced at three time points in all animals in order to assess viral evolution. We report here that seven of the 12 animals controlled viremia to below 10(4) copies/ml of plasma after discontinuation of ART and that this control was associated with a low level of evolutionary divergence. Macaques that controlled viral load developed broader NAb responses early on. Furthermore, escape mutations, such as V67M and R751G, were identified in virus sequenced from all animals with uncontrolled viremia. Bayesian estimation of ancestral population genetic diversity (PGD) showed an increase in this value in non-controlling or transient-controlling animals during the first 5.5 months of infection, in contrast to virus-controlling animals. Similarly, non- or transient controllers displayed more positively-selected amino-acid substitutions. An early increase in PGD, resulting in the generation of positively-selected amino-acid substitutions, greater divergence and relative high viral load after ART withdrawal, may have contributed to the generation of potent NAb in several animals after SIVmac239 infection. However, early broad NAb responses correlated with relatively preserved CD4(+) T-cell numbers, low viral load and limited viral divergence.
format Text
id pubmed-2932721
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29327212010-09-07 Generation of Neutralizing Antibodies and Divergence of SIVmac239 in Cynomolgus Macaques Following Short-Term Early Antiretroviral Therapy Özkaya Şahin, Gülşen Bowles, Emma J. Parker, Joe Uchtenhagen, Hannes Sheik-Khalil, Enas Taylor, Stephen Pybus, Oliver G. Mäkitalo, Barbro Walther-Jallow, Lilian Spångberg, Mats Thorstensson, Rigmor Achour, Adnane Fenyö, Eva Maria Stewart-Jones, Guillaume B. E. Spetz, Anna-Lena PLoS Pathog Research Article Neutralizing antibodies (NAb) able to react to heterologous viruses are generated during natural HIV-1 infection in some individuals. Further knowledge is required in order to understand the factors contributing to induction of cross-reactive NAb responses. Here a well-established model of experimental pathogenic infection in cynomolgus macaques, which reproduces long-lasting HIV-1 infection, was used to study the NAb response as well as the viral evolution of the highly neutralization-resistant SIVmac239. Twelve animals were infected intravenously with SIVmac239. Antiretroviral therapy (ART) was initiated ten days post-inoculation and administered daily for four months. Viral load, CD4(+) T-cell counts, total IgG levels, and breadth as well as strength of NAb in plasma were compared simultaneously over 14 months. In addition, envs from plasma samples were sequenced at three time points in all animals in order to assess viral evolution. We report here that seven of the 12 animals controlled viremia to below 10(4) copies/ml of plasma after discontinuation of ART and that this control was associated with a low level of evolutionary divergence. Macaques that controlled viral load developed broader NAb responses early on. Furthermore, escape mutations, such as V67M and R751G, were identified in virus sequenced from all animals with uncontrolled viremia. Bayesian estimation of ancestral population genetic diversity (PGD) showed an increase in this value in non-controlling or transient-controlling animals during the first 5.5 months of infection, in contrast to virus-controlling animals. Similarly, non- or transient controllers displayed more positively-selected amino-acid substitutions. An early increase in PGD, resulting in the generation of positively-selected amino-acid substitutions, greater divergence and relative high viral load after ART withdrawal, may have contributed to the generation of potent NAb in several animals after SIVmac239 infection. However, early broad NAb responses correlated with relatively preserved CD4(+) T-cell numbers, low viral load and limited viral divergence. Public Library of Science 2010-09-02 /pmc/articles/PMC2932721/ /pubmed/20824092 http://dx.doi.org/10.1371/journal.ppat.1001084 Text en Özkaya Şahin et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Özkaya Şahin, Gülşen
Bowles, Emma J.
Parker, Joe
Uchtenhagen, Hannes
Sheik-Khalil, Enas
Taylor, Stephen
Pybus, Oliver G.
Mäkitalo, Barbro
Walther-Jallow, Lilian
Spångberg, Mats
Thorstensson, Rigmor
Achour, Adnane
Fenyö, Eva Maria
Stewart-Jones, Guillaume B. E.
Spetz, Anna-Lena
Generation of Neutralizing Antibodies and Divergence of SIVmac239 in Cynomolgus Macaques Following Short-Term Early Antiretroviral Therapy
title Generation of Neutralizing Antibodies and Divergence of SIVmac239 in Cynomolgus Macaques Following Short-Term Early Antiretroviral Therapy
title_full Generation of Neutralizing Antibodies and Divergence of SIVmac239 in Cynomolgus Macaques Following Short-Term Early Antiretroviral Therapy
title_fullStr Generation of Neutralizing Antibodies and Divergence of SIVmac239 in Cynomolgus Macaques Following Short-Term Early Antiretroviral Therapy
title_full_unstemmed Generation of Neutralizing Antibodies and Divergence of SIVmac239 in Cynomolgus Macaques Following Short-Term Early Antiretroviral Therapy
title_short Generation of Neutralizing Antibodies and Divergence of SIVmac239 in Cynomolgus Macaques Following Short-Term Early Antiretroviral Therapy
title_sort generation of neutralizing antibodies and divergence of sivmac239 in cynomolgus macaques following short-term early antiretroviral therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932721/
https://www.ncbi.nlm.nih.gov/pubmed/20824092
http://dx.doi.org/10.1371/journal.ppat.1001084
work_keys_str_mv AT ozkayasahingulsen generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT bowlesemmaj generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT parkerjoe generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT uchtenhagenhannes generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT sheikkhalilenas generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT taylorstephen generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT pybusoliverg generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT makitalobarbro generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT waltherjallowlilian generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT spangbergmats generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT thorstenssonrigmor generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT achouradnane generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT fenyoevamaria generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT stewartjonesguillaumebe generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy
AT spetzannalena generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy